- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06127342
Exercise and Emotional Learning in Posttraumatic Stress Disorder
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Christal G Badour, PhD
- Phone Number: 859-323-3817
- Email: christal.badour@uky.edu
Study Locations
-
-
Kentucky
-
Lexington, Kentucky, United States, 40506
- Recruiting
- University Of Kentucky
-
Contact:
- Thomas G Adams, PhD
- Email: tom.adams@uky.edu
-
-
Texas
-
Austin, Texas, United States, 78712
- Recruiting
- University of Texas
-
Contact:
- Josh Cisler, PhD
- Phone Number: 512-495-5162
- Email: josh.cisler@austin.utexas
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults with PTSD related to interpersonal violence
Exclusion Criteria:
- Active or recent (within the last 3 months) severe substance use disorder(s)
- Active or recent (within the last 3 months) suicidal, psychotic, or manic symptoms/ episodes
- Significant developmental disabilities
- Current daily benzodiazepine or stimulant use with inability to abstain for study sessions
- Recent changes in psychiatric medication or trauma focused cognitive-behavioral therapy (CBT) (past 4-weeks)
- Medical condition(s) that prohibit exercise
- History of traumatic brain injury (TBI) with loss of consciousness > 30 mins
- Magnetic resonance imaging (MRI) contraindication(s)
- Positive pregnancy test
- History of seizure disorder
- Spontaneous seizure(s) within the last 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Moderate Intensity Exercise
Visit 1: Participants will complete study screening, PTSD assessments, and provide written narrative for a traumatic event and a neutral control event. Visit 2: Participants will complete baseline structural MRI scans before completing 8 trials of imaginal exposure - 4 neutral then 4 trauma narratives - with psychophysiological and fMRI measurement. Following completion of the imaginal exposure task, the participant will perform Moderate-Intensity Exercise (30-min at 70-75% max HR with 5-min warm-up and 5-min cool-down at 40-50% max HR), on a stationary bike. Visit 3: Participants will complete the same imaginal exposure with measurement of psychophysiology, fMRI, and subjective emotional responding. |
Participants will wear a heartrate monitor and cycle on a stationary bike at a slow speed for 5 minutes, then slowly cycle on a stationary bike for 30 minutes, then cycle on the stationary bike at a slow speed for 5 minutes.
|
|
Active Comparator: Low Intensity Exercise
Visit 1: Participants will complete study screening, PTSD assessments, and provide written narrative for a traumatic event and a neutral control event. Visit 2: Participants will complete baseline structural MRI scans before completing 8 trials of imaginal exposure - 4 neutral then 4 trauma narratives - with psychophysiological and fMRI measurement. Following completion of the imaginal exposure task, the participant will perform Low-Intensity Exercise (control; 40-mins at 40-50% max HR),on a stationary bike. Visit 3: Participants will complete the same imaginal exposure with measurement of psychophysiology, fMRI, and subjective emotional responding. |
Participants will wear a heartrate monitor and cycle on a stationary bike at a slow speed for 40 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in participant subjective emotional ratings
Time Frame: 24 hours
|
Participant anxiety will be measured at baseline and after each imagery trial using a 10-point Likert-type scale with higher scores indicative of more subjective anxiety.
|
24 hours
|
|
Change in Heart Rate
Time Frame: 24 hours
|
Participant heart rate will be measured at baseline and after each imagery trial using a Biopac MP160 system
|
24 hours
|
|
Change in Fear Circuit Blood Oxygen Level-Dependent (BOLD) Response
Time Frame: 48 hours
|
Blood Oxygen Level-Dependent (BOLD) imaging will be measured during each imagery trial
|
48 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christal Badour, PhD, University Of Kentucky
- Principal Investigator: Thomas G Adams, Jr., PhD, University Of Kentucky
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 90369
- R61MH132722 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Supporting Information Type
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PTSD
-
University of PittsburghCompletedPTSD | Non PTSDUnited States
-
COMPASS PathwaysNot yet recruitingPTSD | PTSD, Post Traumatic Stress Disorder | PTSD Symptoms | PTSD - Post Traumatic Stress Disorder
-
Valhalla Project NiagaraRecruiting
-
York UniversityRecruiting
-
VA Office of Research and DevelopmentCompleted
-
Tonix Pharmaceuticals, Inc.Withdrawn
-
University of Wisconsin, MadisonCompleted
-
University of PennsylvaniaUniversity of TexasCompleted
-
Johns Hopkins UniversitySchool of Biomedical Sciences, University of Otago, Dunedin, New Zealand; D...Completed
Clinical Trials on Moderate Intensity Exercise
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
Swinburne University of TechnologyNational Sports Institute of MalaysiaCompletedHealthy | Overweight | Physical InactivityMalaysia
-
Marquette UniversityRecruitingQuality of Life | Pain | Aging | Pain Management | Exercise Training | Aerobic Exercise | Sports | Athlete | Strength Training | Sports Medicine | Strength Training EffectsUnited States
-
University of Texas Southwestern Medical CenterAmerican Heart Association; Biotronik SE & Co. KG; American College of Sports...CompletedHypertrophic CardiomyopathyUnited States
-
Georgia State UniversityEmory UniversityWithdrawn
-
Yale UniversityNot yet recruitingObsessive-Compulsive Disorder (OCD)United States
-
HealthPartners InstituteRecruitingMyasthenia GravisUnited States
-
Cardiff Metropolitan UniversityCardiff UniversityCompletedPolycystic Ovary Syndrome | Exercise | Cerebrovascular CirculationUnited Kingdom
-
University of MiamiCompletedSedentary LifestyleUnited States
-
Norwegian University of Science and TechnologySt. Olavs HospitalActive, not recruiting